Related Experiment Video
Updated: May 10, 2026

Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy
Published on: June 27, 2025
[Developmental dysphasia in children: perspectives of neurotrophic therapy]
Insights
Cerebrolysin treatment significantly improved speech and language skills in children with developmental dysphasia (alalia). The therapy also positively impacted behavior, attention, and motor development in young patients.
Area of Science:
- Pediatrics
- Neurology
- Speech-Language Pathology
Background:
- Developmental dysphasia (alalia) is a severe childhood speech and language disorder.
- Early intervention is crucial for managing developmental dysphasia.
Purpose of the Study:
- To evaluate the efficacy of cerebrolysin in treating developmental dysphasia in young children.
- To assess the impact of cerebrolysin on speech, language, behavior, and motor development.
Main Methods:
- A randomized controlled trial involving 60 children aged 3-4 years with developmental dysphasia.
- Group 1 received cerebrolysin (0.1 ml/kg) for 2 months; Group 2 (controls) received no pharmacotherapy.
- Speech, language, behavior, and motor development were assessed using standardized measures and parent questionnaires.
Main Results:
- Cerebrolysin significantly improved expressive and impressive speech, and speech attention.
- Active vocabulary increased 3.5-fold and phrase use 5-fold in the treatment group compared to 1.5-fold in controls.
- Parents reported decreased behavioral issues (psychasthenic, psychosomatic problems, hyperactivity) and improved attention and emotional control.
Conclusions:
- Cerebrolysin is an effective treatment for developmental dysphasia, enhancing speech, language, and cognitive functions.
- The therapy demonstrated positive effects on motor development and overall behavior in affected children.
- Cerebrolysin offers a promising therapeutic option for children with developmental dysphasia.
Abstract:
Developmental dysphasia (alalia) represents a severe speech and language disorder in children. To assess the efficacy of treatment with cerebrolysin, we have examined 60 children with developmental dysphasia, aged from 3 to 4 years. Group 1 (30 patients) received cerebrolysin (monotherapy, daily dosage 0.1 ml/kg, in the morning hours, on each other day, i.m., 30 injections in total) during 2 months. Group 2 (controls, 30 patients) did not receive pharmacotherapy. A significant improvement of expressive, impressive speech and speech attention was observed in group 1 after the treatment. The active vocabulary increased by a factor of 3.5 and phrases number in colloquial speech by a factor of 5, versus 1.5 in the control group. According to parents' questionnaires, the treatment resulted in the decrease of psychasthenic, psychosomatic problems, motor clumsiness and hyperactivity along with the improvement of attention, emotional control and behavioral measures. The positive effect of cerebrolysin on the motor development was demonstrated by the assessment of motor milestones.
Related Concept Videos
Language and Cognition
Psychosis: Goals of Pharmacotherapy
Language Development
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Traumatic Brain Injury l: Introduction
